Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Diamond and Daved Fremont.
Michael Diamond
Connection Strength
2.316
Daved Fremont
  1. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Rep. 2021 07 27; 36(4):109452.
    View in: PubMed
    Score: 0.239
  2. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
    View in: PubMed
    Score: 0.238
  3. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques. Cell Rep Med. 2021 04 20; 2(4):100230.
    View in: PubMed
    Score: 0.234
  4. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
    View in: PubMed
    Score: 0.233
  5. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell. 2020 10 01; 183(1):169-184.e13.
    View in: PubMed
    Score: 0.225
  6. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice. Cell Host Microbe. 2020 09 09; 28(3):465-474.e4.
    View in: PubMed
    Score: 0.224
  7. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies. Cell. 2020 08 06; 182(3):744-753.e4.
    View in: PubMed
    Score: 0.222
  8. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature. 2018 05; 557(7706):570-574.
    View in: PubMed
    Score: 0.192
  9. Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure. 2005 Jan; 13(1):75-85.
    View in: PubMed
    Score: 0.076
  10. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters. Cell Rep. 2021 07 20; 36(3):109400.
    View in: PubMed
    Score: 0.060
  11. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity. 2021 06 08; 54(6):1290-1303.e7.
    View in: PubMed
    Score: 0.059
  12. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe. 2021 03 10; 29(3):477-488.e4.
    View in: PubMed
    Score: 0.058
  13. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. Proc Natl Acad Sci U S A. 2020 12 15; 117(50):32105-32113.
    View in: PubMed
    Score: 0.057
  14. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. Cell Host Microbe. 2020 09 09; 28(3):475-485.e5.
    View in: PubMed
    Score: 0.056
  15. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. J Immunol. 2020 08 15; 205(4):915-922.
    View in: PubMed
    Score: 0.056
  16. Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice. J Virol. 2018 04 01; 92(7).
    View in: PubMed
    Score: 0.047
  17. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proc Natl Acad Sci U S A. 2006 Aug 15; 103(33):12400-4.
    View in: PubMed
    Score: 0.021
  18. Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b. Adv Exp Med Biol. 2006; 581:115-20.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.